Stockscreener 앱 받기
39.34
4.42%
-1.82
시장 영업 전:
39.30
-0.04
-0.10%
Edgewise Therapeutics Inc 주식(EWTX)의 최신 뉴스
Edgewise Therapeutics Could Benefit From Differentiated EDG-7500 Profile, Oppenheimer Says - marketscreener.com
Edgewise's EDG-7500 Mechanism Lends Confidence, RBC Says - marketscreener.com
H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $57 - moomoo.com
Edgewise Therapeutics, Inc. (EWTX) Stock Price, News, Quote & History - Yahoo! Finance Canada
Edgewise Therapeutics, Inc. (EWTX) Discusses Differentiated Mechanism of Action of Cardiac Sarcomere Modulator EDG-7500Slideshow (NASDAQ:EWTX) 2026-09-22 - Seeking Alpha
EWTX: EDG-7500 improves cardiac relaxation in HCM and advances to Phase 3 after positive Phase 2 data - TradingView
Edgewise unveils mechanism of action for heart drug EDG-7500 By Investing.com - Investing.com Australia
Edgewise unveils mechanism of action for heart drug EDG-7500 - Investing.com
Edgewise Therapeutics unveils EDG-7500, a new d... - Pluang
Edgewise screened more than 7,000 candidates for a heart treatment. EDG-7500 improved relaxation in early tests. - Stock Titan
EWTX Maintained by HC Wainwright & Co. -- Price Target Raised to $57.00 - GuruFocus
HC Wainwright & Co. maintains Buy rating on Edgewise Therapeutics, $57 price target - TradingView
Biotech Options Buzz: UTHR, NMRA, EWTX - Schaeffer's Investment Research
Edgewise Therapeutics stock hits all-time high at 48.41 USD By Investing.com - Investing.com Australia
Edgewise Therapeutics stock hits all-time high at 48.41 USD - Investing.com
CIRRUS-HCM: EDG-7500 Improves LVOT, NYHA Class in oHCM and nHCM - HCPLive
Edgewise Therapeutics Jumps As EDG-7500 Data Fuels Bullish Target Hike - StocksToTrade
Edgewise Therapeutics Stock Jumps As JPMorgan Hikes Target - timothysykes.com
Edgewise Therapeutics Stock Rises as JPMorgan Lifts Price Target - timothysykes.com
Trading Systems Reacting to (EWTX) Volatility - Stock Traders Daily
Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook? - Zacks Investment Research
Analysts Offer Insights on Healthcare Companies: CSL (OtherCMXHF) and Edgewise Therapeutics (EWTX) - The Globe and Mail
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules - PR Newswire
Four new employees receive stock awards from Edgewise - Stock Titan
RBC Capital Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $59 - Moomoo
The Technical Signals Behind (EWTX) That Institutions Follow - Stock Traders Daily
Edgewise Therapeutics Announces Upcoming Late-Breaking Science Presentation at the European Society of Cardiology (ESC) Congress 2026 - PR Newswire
Edgewise Therapeutics Reports Second Quarter 2026 Financial Results - Eastern Progress
Edgewise Therapeutics Is Maintained at Overweight by JP Morgan - Moomoo
EWTX Maintains Overweight Rating -- Price Target Raised to $60 - GuruFocus
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Edgewise Therapeutics (NASDAQ:EWTX) Stock - MarketBeat
Edgewise Therapeutics (EWTX) Is Up 6.6% After Wider Q2 Losses Highlight Rising SpendHas The Bull Case Changed? - simplywall.st
CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? - Stocktwits
Edgewise (EWTX) Results and Estimates: The Available Earnings Metric Delivers a Miss in the Available Record; Price Reaction: The Stock Ends Up 0.16% in Latest TradingConsensus Miss Rate - vinanet.vn
Edgewise Therapeutics: Servier Deal Creates A Self-Funded Cardiovascular Platform (EWTX) - Seeking Alpha
Edgewise Therapeutics (EWTX) corrects CFO option grant price - Stock Titan
Edgewise Therapeutics (EWTX) corrects CMO’s 65K option grant price - Stock Titan
Edgewise Therapeutics (EWTX) sets GC option price at $43.56 - Stock Titan
Edgewise Therapeutics (EWTX) gives CSO 65K options at $43.56 - Stock Titan
Edgewise (NASDAQ: EWTX) CBO gets 100K options vesting from 2026 - Stock Titan
69,441 Shares in Edgewise Therapeutics, Inc. $EWTX Bought by Persistent Asset Partners Ltd - MarketBeat
44,466 Shares in Edgewise Therapeutics, Inc. $EWTX Bought by GSA Capital Partners LLP - MarketBeat
Edgewise Therapeutics (EWTX) Reports Wider Losses On A Valuation That Still Looks Rich - Sahm
Edgewise Therapeutics (EWTX) Gains 2.29% to $44.17, Maintains Upside MomentumStock Surge Alerts - vinanet.vn
Edgewise Therapeutics general counsel Moore sells $219,822 in shares - Investing.com
Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock By Investing.com - Investing.com South Africa
Edgewise Therapeutics CSO Alan Russell sells $258k in stock - Investing.com
Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock - Investing.com
Edgewise Therapeutics CSO Alan Russell sells $258k in stock By Investing.com - Investing.com South Africa
Edgewise Therapeutics CMO Joanne Donovan sells $412,703 in stock - Investing.com
Edgewise Therapeutics CBO sells $223k in shares for tax obligations - Investing.com
Edgewise Therapeutics general counsel Moore sells $219,822 in shares By Investing.com - Investing.com Australia
Edgewise Therapeutics CMO Joanne Donovan sells $412,703 in stock By Investing.com - Investing.com Canada
3.06%
2.55%
자본화:
|
볼륨(24시간):